Movers & Shakers: 3M, Hawaiian Electric stocks surge, NovoCure shares plunge and other stocks on the move

Shares of 3M Co.
MMM,
+5.22%
rose 3.7%, enough to pace the Dow Jones Industrial Average’s
DJIA
gainers, after The Wall Street Journal reported that the multinational conglomerate was nearing agreement on a $5.5 billion plan to settle more than 300,000 lawsuits over defective military earplugs.

XPeng Inc.
XPEV,
+5.31%
stock climbed 2.4% after the China electric vehicle maker announced a strategic partnership with mobile tech platform DiDi Global Inc.
DIDIY,
+3.15%,
buying its smart auto development business. DiDi’s U.S.-listed shares gained 2.8%.

Hersha Hospitality Trust shares
HT,
+55.89%
ran up 56% toward a record one-day gain after the real-estate investment trust focused on the hospitality sector announced an agreement to be acquired by private-equity firm KSL Capital Partners LLC in a cash deal valued at $1.4 billion.

Thorne HealthTech Inc.’s stock THRN rallied 29% after the wellness company said it agreed to be taken private by L Catterton for $10.20 a share in cash in a deal valued at $680 million.

Shares of Horizon Therapeutics PLC
HZNP,
+5.14%
climbed 6% after the Federal Trade Commission paused its legal challenge to Amgen Inc.’s deal to acquire the biotech company for $27.8 billion.

RPT Realty‘s stock
RPT,
+17.35%
hiked up 19% after the New York-based shopping center owner announced an agreement to be acquired by Kimco Realty Corp. in an all-stock deal valued at $2 billion including debt. Kimco’s stock
KIM,
+0.16%
gained 1.2%.

BrightView Holdings Inc. shares
BV,
+7.36%
got an 11% boost after the commercial landscaping services company said it received a $500 million investment from private-equity firm Rock Capital Partners LLC.

GD Culture Group Ltd. shares
GDC,
+37.80%
shot up 64% after the Hong Kong-based small-capitalization company said it plans to enter the live-streaming e-commerce business launched on the social-media platform TikTok.

Stock decliners

Shares of NovoCure Ltd.
NVCR,
-37.50%
plummeted 33% toward a five-year low after the oncology company said a late-stage trial of its ovarian cancer treatment failed to meet its primary endpoint.

CrowdStrike Holdings Inc.’s stock
CRWD,
-3.71%
dropped 2.4% after the cybersecurity company was downgraded to equal weight from overweight at Morgan Stanley, citing signs of a further industry slowdown and cloud optimization headwinds.

ImmunoGen Inc. shares
IMGN,
-3.66%
shed 6.5%, to reverse an earlier premarket gain, after the Massachusetts-based drugmaker announced a collaboration with Takeda Pharmaceutical Co. Ltd. 
TAK,
+0.33%

4502,
+0.52%
to commercialize its Elahere ovarian cancer treatment in Japan.